These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16672143)

  • 1. Uric acid and the vasculature.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 2006 May; 8(2):116-9. PubMed ID: 16672143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
    Riegersperger M; Covic A; Goldsmith D
    Int Urol Nephrol; 2011 Jun; 43(2):441-9. PubMed ID: 21547469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
    Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
    J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.
    Sautin YY; Nakagawa T; Zharikov S; Johnson RJ
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C584-96. PubMed ID: 17428837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and endothelial function: From molecular background to clinical perspectives.
    Maruhashi T; Hisatome I; Kihara Y; Higashi Y
    Atherosclerosis; 2018 Nov; 278():226-231. PubMed ID: 30326405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hyperuricemia in vascular disorders.
    Edwards NL
    Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid as one of the important factors in multifactorial disorders--facts and controversies.
    Pasalic D; Marinkovic N; Feher-Turkovic L
    Biochem Med (Zagreb); 2012; 22(1):63-75. PubMed ID: 22384520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
    Grassi D; Ferri L; Desideri G; Di Giosia P; Cheli P; Del Pinto R; Properzi G; Ferri C
    Curr Pharm Des; 2013; 19(13):2432-8. PubMed ID: 23173592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells.
    Komori H; Yamada K; Tamai I
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):973-980. PubMed ID: 29317200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uric acid as a risk factor for cardiovascular diseases].
    Cibičková Ľ; Karásek D
    Vnitr Lek; 2016; 62(11):919-923. PubMed ID: 28128580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection.
    Bahadoran Z; Mirmiran P; Kashfi K; Ghasemi A
    Pflugers Arch; 2022 Jan; 474(1):83-98. PubMed ID: 34313822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production.
    Papežíková I; Pekarová M; Kolářová H; Klinke A; Lau D; Baldus S; Lojek A; Kubala L
    Free Radic Res; 2013 Feb; 47(2):82-8. PubMed ID: 23136942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of uric acid in the pathogenesis of human cardiovascular disease.
    Kanbay M; Segal M; Afsar B; Kang DH; Rodriguez-Iturbe B; Johnson RJ
    Heart; 2013 Jun; 99(11):759-66. PubMed ID: 23343689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid as a pathogenic factor in preeclampsia.
    Bainbridge SA; Roberts JM
    Placenta; 2008 Mar; 29 Suppl A(Suppl A):S67-72. PubMed ID: 18093648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The uric acid cardio-nephropathy].
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights.
    Gulab A; Torres R; Pelayo J; Lo KB; Shahzad A; Pradhan S; Rangaswami J
    Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):547-556. PubMed ID: 34112023
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperuricemia induces endothelial dysfunction.
    Khosla UM; Zharikov S; Finch JL; Nakagawa T; Roncal C; Mu W; Krotova K; Block ER; Prabhakar S; Johnson RJ
    Kidney Int; 2005 May; 67(5):1739-42. PubMed ID: 15840020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.